| VRTX Vertex Pharmaceuticals | Biotechnology | $132.0B | 66 |
| REGN Regeneron Pharmaceuticals | Biotechnology | $95.5B | 69 |
| MRNA Moderna | Biotechnology | $80.7B | 47 |
| ARGX argenx | Biotechnology | $59.2B | 72 |
| ONC BeOne Medicines | Biotechnology | $45.7B | 69 |
| RPRX Royalty Pharma | Biotechnology | $38.9B | 61 |
| RVMD Revolution Medicines | Biotechnology | $34.5B | 43 |
| INSM Insmed | Biotechnology | $31.7B | 56 |
| GMAB Genmab A/S | Biotechnology | $31.7B | 66 |
| ROIV Roivant Sciences | Biotechnology | $28.2B | 33 |
| INCY Incyte | Biotechnology | $23.6B | 67 |
| BNTX BioNTech | Biotechnology | $20.2B | 44 |
| ALNY Alnylam Pharmaceuticals | Biotechnology | $19.8B | 66 |
| ASND Ascendis Pharma A/S | Biotechnology | $16.8B | 66 |
| EXEL Exelixis | Biotechnology | $16.1B | 76 |
| BBIO BridgeBio Pharma | Biotechnology | $15.2B | 57 |
| JAZZ Jazz Pharmaceuticals | Biotechnology | $15.2B | 61 |
| BMRN BioMarin Pharmaceutical | Biotechnology | $11.9B | 63 |
| TECH Bio-Techne | Biotechnology | $11.4B | 63 |
| HALO Halozyme Therapeutics | Biotechnology | $10.6B | 71 |
| KYMR Kymera Therapeutics | Biotechnology | $10.2B | 44 |
| TGTX TG Therapeutics | Biotechnology | $9.8B | 73 |
| KRYS Krystal Biotech | Biotechnology | $9.4B | 71 |
| SYRE Spyre Therapeutics | Biotechnology | $9.3B | 46 |
| PCVX Vaxcyte | Biotechnology | $9.2B | 38 |
| MDGL Madrigal Pharmaceuticals | Biotechnology | $9.2B | 55 |
| PRAX Praxis Precision Medicines | Biotechnology | $8.7B | 50 |
| SMMT Summit Therapeutics | Biotechnology | $8.5B | 38 |
| RYTM Rhythm Pharmaceuticals | Biotechnology | $8.1B | 56 |
| PTGX Protagonist Therapeutics | Biotechnology | $8.1B | 60 |
| TWST Twist Bioscience | Biotechnology | $7.6B | 50 |
| CGON CG Oncology | Biotechnology | $7.3B | 52 |
| CYTK Cytokinetics | Biotechnology | $7.2B | 49 |
| AXSM Axsome Therapeutics | Biotechnology | $7.1B | 53 |
| CORT Corcept Therapeutics | Biotechnology | $7.1B | 61 |
| ABVX ABIVAX Société Anonyme | Biotechnology | $7.1B | 30 |
| IBRX ImmunityBio | Biotechnology | $7.0B | 55 |
| IMVT Immunovant | Biotechnology | $6.7B | 35 |
| ORKA Oruka Therapeutics | Biotechnology | $6.6B | 34 |
| KOD Kodiak Sciences | Biotechnology | $6.4B | 35 |
| MIRM Mirum Pharmaceuticals | Biotechnology | $6.2B | 58 |
| ARWR Arrowhead Pharmaceuticals | Biotechnology | $6.2B | 39 |
| SRRK Scholar Rock Holding | Biotechnology | $6.1B | 47 |
| BLTE Belite Bio | Biotechnology | $6.1B | 40 |
| LGND Ligand Pharmaceuticals | Biotechnology | $5.7B | 61 |
| CAI Caris Life Sciences | Biotechnology | $5.3B | 53 |
| ERAS Erasca | Biotechnology | $5.0B | 38 |
| PTCT PTC Therapeutics | Biotechnology | $4.9B | 69 |
| COGT Cogent Biosciences | Biotechnology | $4.8B | 40 |
| DNTH Dianthus Therapeutics | Biotechnology | $4.8B | 49 |
| TVTX Travere Therapeutics | Biotechnology | $4.6B | 57 |
| IONS Ionis Pharmaceuticals | Biotechnology | $4.5B | 36 |
| EWTX Edgewise Therapeutics | Biotechnology | $4.5B | 46 |
| TNGX Tango Therapeutics | Biotechnology | $3.8B | 47 |
| TARS Tarsus Pharmaceuticals | Biotechnology | $3.8B | 56 |
| CRSP CRISPR Therapeutics | Biotechnology | $3.8B | 43 |
| XENE Xenon Pharmaceuticals | Biotechnology | $3.7B | 40 |
| VRDN Viridian Therapeutics | Biotechnology | $3.6B | 53 |
| RLAY Relay Therapeutics | Biotechnology | $3.5B | 41 |
| IRON Disc Medicine | Biotechnology | $3.5B | 38 |
| ARQT Arcutis Biotherapeutics | Biotechnology | $3.4B | 59 |
| ABCL AbCellera Biologics | Biotechnology | $3.4B | 49 |
| ELVN Enliven Therapeutics | Biotechnology | $3.4B | 39 |
| IOVA Iovance Biotherapeutics | Biotechnology | $3.4B | 55 |
| VKTX Viking Therapeutics | Biotechnology | $3.3B | 28 |
| LEGN Legend Biotech | Biotechnology | $3.1B | 52 |
| ACAD Acadia Pharmaceuticals | Biotechnology | $3.0B | 62 |
| SLS SELLAS Life Sciences Group | Biotechnology | $3.0B | 50 |
| DYN Dyne Therapeutics | Biotechnology | $3.0B | 29 |
| VCEL Vericel | Biotechnology | $3.0B | 66 |
| ADMA ADMA Biologics | Biotechnology | $3.0B | 70 |
| TLX Telix Pharmaceuticals | Biotechnology | $3.0B | 53 |
| DNLI Denali Therapeutics | Biotechnology | $2.9B | 44 |
| CELC Celcuity | Biotechnology | $2.8B | 26 |
| ZLAB Zai Lab | Biotechnology | $2.7B | 49 |
| MBX MBX Biosciences | Biotechnology | $2.7B | 37 |
| XNCR Xencor | Biotechnology | $2.6B | 41 |
| IDYA IDEAYA Biosciences | Biotechnology | $2.5B | 41 |
| NAMS NewAmsterdam Pharma Company | Biotechnology | $2.3B | 43 |
| RCUS Arcus Biosciences | Biotechnology | $2.3B | 36 |
| PHVS Pharvaris | Biotechnology | $2.2B | 39 |
| CLDX Celldex Therapeutics | Biotechnology | $2.2B | 29 |
| BEAM Beam Therapeutics | Biotechnology | $2.2B | 41 |
| PVLA Palvella Therapeutics | Biotechnology | $2.1B | 41 |
| BHVN Biohaven | Biotechnology | $2.1B | 40 |
| AUPH Aurinia Pharmaceuticals | Biotechnology | $2.0B | 73 |
| IMNM Immunome | Biotechnology | $2.0B | 36 |
| TRVI Trevi Therapeutics | Biotechnology | $2.0B | 40 |
| FTRE Fortrea | Biotechnology | $1.9B | 47 |
| HRMY Harmony Biosciences | Biotechnology | $1.9B | 72 |
| VERA Vera Therapeutics | Biotechnology | $1.9B | 31 |
| ZYME Zymeworks | Biotechnology | $1.9B | 53 |
| MRVI Maravai LifeSciences | Biotechnology | $1.9B | 43 |
| SEPN Septerna | Biotechnology | $1.9B | 56 |
| REPL Replimune Group | Biotechnology | $1.8B | 41 |
| MAZE Maze Therapeutics | Biotechnology | $1.8B | 34 |
| STOK Stoke Therapeutics | Biotechnology | $1.8B | 52 |
| RARE Ultragenyx Pharmaceutical | Biotechnology | $1.8B | 47 |
| AGIO Agios Pharmaceuticals | Biotechnology | $1.7B | 47 |
| ZBIO Zenas BioPharma | Biotechnology | $1.7B | 31 |
| RXRX Recursion Pharmaceuticals | Biotechnology | $1.7B | 45 |
| VIR Vir Biotechnology | Biotechnology | $1.7B | 54 |
| URGN UroGen Pharma | Biotechnology | $1.6B | 58 |
| SRPT Sarepta Therapeutics | Biotechnology | $1.5B | 41 |
| PGEN Precigen | Biotechnology | $1.5B | 52 |
| NRIX Nurix Therapeutics | Biotechnology | $1.5B | 56 |
| MESO Mesoblast | Biotechnology | $1.5B | 49 |
| QURE uniQure | Biotechnology | $1.4B | 45 |
| ABSI Absci | Biotechnology | $1.4B | 27 |
| ANAB AnaptysBio | Biotechnology | $1.4B | 69 |
| RAPP Rapport Therapeutics | Biotechnology | $1.4B | 32 |
| NBTX Nanobiotix | Biotechnology | $1.4B | 48 |
| IMCR Immunocore Holdings | Biotechnology | $1.4B | 51 |
| TYRA Tyra Biosciences | Biotechnology | $1.4B | 31 |
| NUVB Nuvation Bio | Biotechnology | $1.3B | 40 |
| NTLA Intellia Therapeutics | Biotechnology | $1.3B | 33 |
| INVA Innoviva | Biotechnology | $1.3B | 63 |
| LBRX LB Pharmaceuticals | Biotechnology | $1.3B | 41 |
| OCUL Ocular Therapeutix | Biotechnology | $1.3B | 38 |
| GHRS GH Research | Biotechnology | $1.3B | 42 |
| NVAX Novavax | Biotechnology | $1.3B | 55 |
| MNKD MannKind | Biotechnology | $1.3B | 56 |
| MLYS Mineralys Therapeutics | Biotechnology | $1.3B | 31 |
| SLN Silence Therapeutics | Biotechnology | $1.2B | 55 |
| TSHA Taysha Gene Therapies | Biotechnology | $1.2B | 47 |
| GPCR Structure Therapeutics | Biotechnology | $1.2B | 29 |
| AAPG Ascentage Pharma Group Internat | Biotechnology | $1.2B | 45 |
| SVRA Savara | Biotechnology | $1.1B | 38 |
| VOR Vor Biopharma | Biotechnology | $1.1B | 43 |
| NKTR Nektar Therapeutics | Biotechnology | $1.1B | 27 |
| INBX Inhibrx Biosciences | Biotechnology | $1.1B | 38 |
| ANRO Alto Neuroscience | Biotechnology | $1.1B | 36 |
| DRTS Alpha Tau Medical | Biotechnology | $1.0B | 30 |
| OMER Omeros | Biotechnology | $1.0B | 57 |
| JBIO Jade Biosciences | Biotechnology | $1.0B | 36 |